SMAD3 and benign prostatic hyperplasia: It was reported that the phosphorylation of SMAD3 can promote the differentiation of fibroblasts into myofibroblasts, fibrosis, and EMT during the progression of BPH (Sheng et al., 2018; Tang et al., 2019; Chen et al., 2021).